SINTX Technologies Return on Equity

SINTX Technologies (SINT) currently reports a ROE of -372.67%. That is below the Healthcare sector average of -100.59%. Use the charts on this page to explore SINTX Technologies's ROE history and peer comparisons.

SINTX Technologies's ROE of -372.67% is lower than the Healthcare sector average of -100.59%. That is roughly 270.5% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but SINTX Technologies's current -372.67% should be judged against Healthcare norms (sector average: -100.59%) and against SINT's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of -372.67%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is -100.59%. From there, open related valuation or income-statement pages for SINTX Technologies, and consider following SINT for alerts when major investors trade the stock.

SINTX Technologies is classified in the Healthcare sector. On ROE, it currently shows -372.67% versus a sector average near -100.59%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SINT with unrelated industries.